Stocktoria
Kymera Therapeutics, Inc. KYMR
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-08-21
Kymera Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 4,155,429 | $124.0M | 4.92% |
| TWO SIGMA INVESTMENTS, LP | 371,374 | $42.6M | 0.44% |
| CITADEL ADVISORS LLC | 174,955 | $20.1M | 0.21% |
| AQR CAPITAL MANAGEMENT LLC | 9,541 | $1.1M | 0.01% |
| D. E. Shaw & Co., Inc. | 2,800 | $321,076 | — |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.